FDA Inspection 1168713 — NYC Health + Hospitals/Bellevue

NYC Health + Hospitals/Bellevue — FEI 2473466

The FDA completed an inspection of NYC Health + Hospitals/Bellevue on May 6, 2022 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 6, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs